rdf:type |
|
lifeskim:mentions |
umls-concept:C0021439,
umls-concept:C0023903,
umls-concept:C0026336,
umls-concept:C0031268,
umls-concept:C0031809,
umls-concept:C0032743,
umls-concept:C0046056,
umls-concept:C0054130,
umls-concept:C0087111,
umls-concept:C0450442,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
2
|
pubmed:dateCreated |
2011-1-28
|
pubmed:abstractText |
The purpose of this study was to determine the effects of 3-bromopyruvate (3-BrPA) on tumor glucose metabolism as imaged with (18)F-FDG PET/CT at multiple time points after treatment and compare them with those after intraarterial control injections of saline.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1535-5667
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
225-30
|
pubmed:dateRevised |
2011-3-30
|
pubmed:meshHeading |
pubmed-meshheading:21233194-Angiography,
pubmed-meshheading:21233194-Animals,
pubmed-meshheading:21233194-Enzyme Inhibitors,
pubmed-meshheading:21233194-Fluorodeoxyglucose F18,
pubmed-meshheading:21233194-Image Processing, Computer-Assisted,
pubmed-meshheading:21233194-Infusions, Intra-Arterial,
pubmed-meshheading:21233194-Liver,
pubmed-meshheading:21233194-Liver Circulation,
pubmed-meshheading:21233194-Liver Neoplasms, Experimental,
pubmed-meshheading:21233194-Male,
pubmed-meshheading:21233194-Neoplasm Transplantation,
pubmed-meshheading:21233194-Pharmaceutical Solutions,
pubmed-meshheading:21233194-Positron-Emission Tomography,
pubmed-meshheading:21233194-Pyruvate Dehydrogenase Complex,
pubmed-meshheading:21233194-Pyruvates,
pubmed-meshheading:21233194-Rabbits,
pubmed-meshheading:21233194-Radiopharmaceuticals,
pubmed-meshheading:21233194-Tomography, Emission-Computed
|
pubmed:year |
2011
|
pubmed:articleTitle |
Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor.
|
pubmed:affiliation |
Division of Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland 21287-0817, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|